The Key Cellular Senescence Related Molecule RRM2 Regulates Prostate Cancer Progression and Resistance to Docetaxel Treatment

The authors explored the role of Ribonucleotide reductase subunit M2 (RRM2), a gene associated with senescence, in the sensitivity of prostate cancer to docetaxel.